Celularity Inc. (NASDAQ:CELUW) Short Interest Update

Celularity Inc. (NASDAQ:CELUW) was the target of a large growth in short interest in February. As of February 27th, there was short interest totaling 1,729 shares, a growth of 219.0% from the February 12th total of 542 shares. Based on an average trading volume of 3,971 shares, the days-to-cover ratio is currently 0.4 days. Based on an average trading volume of 3,971 shares, the days-to-cover ratio is currently 0.4 days.

Celularity Price Performance

Celularity stock opened at $0.01 on Wednesday. Celularity has a 12 month low of $0.01 and a 12 month high of $0.75. The stock has a fifty day simple moving average of $0.01 and a two-hundred day simple moving average of $0.02.

About Celularity

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.